Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 169
Journal of Mucosal Immunology Research received 169 citations as per Google Scholar report
Journal of Mucosal Immunology Research peer review process verified at publons
Indexed In
- Google Scholar
- Publons
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Mucosal Immunotherapy
Mucosal Immunotherapy aims to harness and modulate the immune responses at mucosal surfaces, such as the gastrointestinal tract, respiratory tract, and oral cavity. This approach involves administering antigens or immune-modulating agents directly to mucosal sites to induce protective immunity or tolerance. Research focuses on optimizing delivery methods, enhancing efficacy, and minimizing side effects. Key areas include developing mucosal vaccines for infectious diseases and allergies, using biologics to treat chronic inflammatory conditions like inflammatory bowel disease, and exploring novel therapeutic strategies to correct mucosal immune dysfunction. Mucosal immunotherapy holds promise for targeted and effective treatment of a range of mucosal diseases.
Mucosal Immunotherapy
Expert PPTs
- Jun Yang
Histopathology and pathogenesis of digestive system and Female genital and breast tumors
PPT Version | PDF Version
Speaker PPTs
- Ganapathi Bhat Mugulthimoole
Unmasking the masquerading cancer cells: have we made progress with the revival of immunotherapy?
PPT Version | PDF Version - Inge Verbrugge
Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applications
PPT Version | PDF Version - Phillip K. Darcy
Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
PPT Version | PDF Version - Yvonne Paterson
HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
PPT Version | PDF Version - Leonora Hana-Lleshi
The efficiency of immunotherapy to the subjects with allergy to bee venom and its influence in pollen allergy
| PDF Version - Luljeta Ahmetaj
The role of Specific Immunotherapy in reduction of viral infections in asthmatic patients
PPT Version | PDF Version - Rahul Purwar
Engineered T cells: Next-generation cancer immunotherapy
PPT Version | PDF Version - John A. Barrett
Localized regulated expression of IL-12 as a gene therapy approach to cancer immunotherapy
PPT Version | PDF Version - Elena Gavrilova
Application of drugs based on release-active antibodies as immunotherapy agents
PPT Version | PDF Version